Cite
Sanabria A, Pinillos P, Lira RB, et al. Current therapeutic options for low-risk papillary thyroid carcinoma: Scoping evidence review. Head Neck. 2021;44(1):226-237doi: 10.1002/hed.26883.
Sanabria, A., Pinillos, P., Lira, R. B., Shah, J. P., Tufano, R. P., Zafereo, M. E., Nixon, I. J., Randolph, G. W., Simo, R., Vander Poorten, V., Rinaldo, A., Medina, J. E., Khafif, A., Angelos, P., Mäkitie, A. A., Shaha, A. R., Rodrigo, J. P., Hartl, D. M., Kowalski, L. P., & Ferlito, A. (2022). Current therapeutic options for low-risk papillary thyroid carcinoma: Scoping evidence review. Head & neck, 44(1), 226-237. https://doi.org/10.1002/hed.26883
Sanabria, Alvaro, et al. "Current therapeutic options for low-risk papillary thyroid carcinoma: Scoping evidence review." Head & neck vol. 44,1 (2022): 226-237. doi: https://doi.org/10.1002/hed.26883
Sanabria A, Pinillos P, Lira RB, Shah JP, Tufano RP, Zafereo ME, Nixon IJ, Randolph GW, Simo R, Vander Poorten V, Rinaldo A, Medina JE, Khafif A, Angelos P, Mäkitie AA, Shaha AR, Rodrigo JP, Hartl DM, Kowalski LP, Ferlito A. Current therapeutic options for low-risk papillary thyroid carcinoma: Scoping evidence review. Head Neck. 2022 Jan;44(1):226-237. doi: 10.1002/hed.26883. Epub 2021 Sep 30. PMID: 34590380.
Copy
Download .nbib